Autologous Induced Pluripotent Stem Cells(HeartWorks, Inc.)

The goal of this clinical trial is to test the safety of lab-grown heart cells made from stem cells in subjects with congenital heart disease. The main questions it aims to answer are:
Is this product safe to deliver to humans
Is the conduct of this trial feasible
Participants will be asked to:
Agree to testing and monitoring before and after product administration
Receive investigational product
Agree to lifelong follow-up Researchers will compare subjects from the same pool to see if there is a difference between treated and untreated subjects.